Ginkgo Bioworks Holdings Inc (DNA)
0.955
+0.09
(+10.90%)
USD |
NYSE |
May 03, 16:00
0.94
-0.02
(-1.57%)
After-Hours: 20:00
Ginkgo Bioworks Holdings Total Assets (Quarterly): 1.665B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.665B |
| September 30, 2023 | 2.026B |
| June 30, 2023 | 2.292B |
| March 31, 2023 | 2.417B |
| December 31, 2022 | 2.539B |
| September 30, 2022 | 1.871B |
| Date | Value |
|---|---|
| June 30, 2022 | 1.994B |
| March 31, 2022 | 2.058B |
| December 31, 2021 | 2.071B |
| September 30, 2021 | 2.151B |
| December 31, 2020 | 675.15M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
675.15M
Minimum
Dec 2020
2.539B
Maximum
Dec 2022
1.978B
Average
2.058B
Median
Mar 2022
Total Assets (Quarterly) Benchmarks
| Agenus Inc | 313.91M |
| Teladoc Health Inc | 4.321B |
| Sarepta Therapeutics Inc | 3.224B |
| Ultragenyx Pharmaceutical Inc | 1.491B |
| Apellis Pharmaceuticals Inc | 788.73M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 568.19M |
| Shareholders Equity (Quarterly) | 1.097B |
| Current Ratio | 6.113 |